Investors bought shares of UnitedHealth Group Inc (NYSE:UNH) on weakness during trading hours on Wednesday. $148.09 million flowed into the stock on the tick-up and $99.38 million flowed out of the stock on the tick-down, for a money net flow of $48.71 million into the stock. Of all equities tracked, UnitedHealth Group had the 23rd highest net in-flow for the day. UnitedHealth Group traded down ($1.68) for the day and closed at $224.20
UNH has been the subject of several analyst reports. Goldman Sachs Group initiated coverage on UnitedHealth Group in a report on Wednesday, January 3rd. They issued a “buy” rating and a $269.00 price target for the company. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, September 26th. Morgan Stanley boosted their price objective on shares of UnitedHealth Group from $215.00 to $235.00 and gave the company an “overweight” rating in a research note on Wednesday, October 18th. ValuEngine cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 5th. Finally, Leerink Swann reissued a “buy” rating and set a $240.00 price objective (up from $225.00) on shares of UnitedHealth Group in a research note on Wednesday, October 18th. Three investment analysts have rated the stock with a hold rating and twenty-five have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $226.74.
The company has a debt-to-equity ratio of 0.52, a current ratio of 0.70 and a quick ratio of 0.70. The stock has a market capitalization of $216,770.00, a PE ratio of 25.48, a price-to-earnings-growth ratio of 1.57 and a beta of 0.66.
The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 12th. Investors of record on Friday, December 1st were given a dividend of $0.75 per share. The ex-dividend date was Thursday, November 30th. This represents a $3.00 dividend on an annualized basis and a yield of 1.34%. UnitedHealth Group’s dividend payout ratio (DPR) is 34.09%.
In related news, Director Gail R. Wilensky sold 5,600 shares of the company’s stock in a transaction on Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the completion of the sale, the director now directly owns 61,137 shares of the company’s stock, valued at approximately $13,652,503.47. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Thomas E. Roos sold 975 shares of the company’s stock in a transaction on Thursday, October 19th. The stock was sold at an average price of $205.47, for a total transaction of $200,333.25. Following the sale, the insider now directly owns 24,630 shares of the company’s stock, valued at $5,060,726.10. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 34,630 shares of company stock valued at $7,669,416. 0.89% of the stock is owned by corporate insiders.
A number of institutional investors have recently made changes to their positions in the stock. Pure Financial Advisors Inc. purchased a new position in UnitedHealth Group in the 4th quarter valued at about $219,000. White Lighthouse Investment Management Inc. purchased a new position in UnitedHealth Group in the 4th quarter valued at about $295,000. Hutchens Investment Management Inc boosted its position in UnitedHealth Group by 8.2% in the 4th quarter. Hutchens Investment Management Inc now owns 8,144 shares of the healthcare conglomerate’s stock valued at $1,795,000 after buying an additional 619 shares during the last quarter. Oak Point Wealth Management purchased a new position in UnitedHealth Group in the 4th quarter valued at about $1,426,000. Finally, Abner Herrman & Brock LLC boosted its position in UnitedHealth Group by 8.7% in the 4th quarter. Abner Herrman & Brock LLC now owns 33,428 shares of the healthcare conglomerate’s stock valued at $7,370,000 after buying an additional 2,669 shares during the last quarter. 86.01% of the stock is owned by hedge funds and other institutional investors.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
What are top analysts saying about UnitedHealth Group? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for UnitedHealth Group and related companies.